Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[How to recognize scleroderma].

Camille Francès1, Nakhle Ayoub, Stéphane Barete

  • 1Service de médecine interne Groupe hospitalier La Pitié-La Salpêtrière 75651 Paris. camille.frances@psl.ap-hop-paris.fr

La Revue Du Praticien
|January 21, 2003
PubMed
Summary

Systemic sclerosis is an autoimmune disorder causing connective tissue, vascular, and skin changes. Differentiating its subtypes, like CREST syndrome, is crucial for prognosis and treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PDE4 inhibitor mitigates activated CD8+ T cells through NF-κB signaling in Behçet's syndrome.

Frontiers in immunology·2026
Same author

Sustained clinical remission of epidermolysis bullosa simplex due to a pathogenic KRT14 variant in a 7-year-old girl.

JAAD case reports·2026
Same author

Outcomes and prognostic factors in patients with systemic mastocytosis and an associated myeloid neoplasm: an international ECNM registry study.

Journal of hematology & oncology·2026
Same author

Clonal expansion of CAR-T cells harboring lentivector integration in the PLAAT4 gene following anti-CD19 CAR T-cell therapy in a context of cutaneous T-cell lymphoma.

Haematologica·2026
Same author

Avapritinib achieves long-term disease control with favorable safety in patients with indolent systemic mastocytosis over 3 years.

The Journal of allergy and clinical immunology·2026
Same author

EULAR recommendations for the management of Behçet's syndrome: 2025 update.

Annals of the rheumatic diseases·2026

Area of Science:

  • Rheumatology
  • Dermatology
  • Immunology

Context:

  • Systemic sclerosis is a complex multisystem autoimmune disease.
  • It involves connective tissue sclerosis, vascular abnormalities, and autoimmune phenomena.
  • Raynaud's phenomenon often precedes systemic sclerosis, and cutaneous changes aid diagnosis.

Purpose:

  • To differentiate systemic sclerosis from morphea and other scleroderma-like conditions.
  • To highlight diagnostic and prognostic indicators within systemic sclerosis subtypes.
  • To describe the clinical and histological features of systemic sclerosis and morphea.

Summary:

  • Systemic sclerosis presents with sclerosis, vascular issues, and autoimmunity, often preceded by Raynaud's phenomenon.
  • Cutaneous manifestations, like pitted scars, telangiectases, and calcium deposits, are key diagnostic clues.
  • Subtypes include CREST syndrome (good prognosis) and diffuse cutaneous sclerosis (poor prognosis), distinguished by antibody profiles and organ involvement.

Impact:

  • Accurate diagnosis and subtype classification are essential for predicting disease progression and patient outcomes.
  • Understanding the distinct features of systemic sclerosis, morphea, and mimic conditions improves patient management.
  • Identifying specific autoantibodies aids in risk stratification for complications like pulmonary hypertension or fibrosis.

Related Experiment Videos